{"entity":{"type":"insider","cik":"0001733077","url":"/insider/0001733077","json_url":"/insider/0001733077.json","name":"ROSS ROBERT W.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":10,"n_filings":9,"first":"2020-10-16","last":"2023-08-11","span_basis":"filed_date"},"name_variants":[{"name":"ROSS ROBERT W.","source":"filing","n_filings":9,"first_seen":"2020-10-16","last_seen":"2023-08-11"}],"transactions":[{"id":8295751,"accession":"0001209191-23-045494","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-045494","line_url":"/filing/0001209191-23-045494#line-1","is_derivative":false,"issuer_cik":"0001718108","issuer_name":"Surface Oncology, Inc.","issuer_ticker":"SURF","issuer_name_source":null,"issuer_url":"/issuer/0001718108","owner_cik":"0001733077","owner_name":"ROSS ROBERT W.","owner_url":"/insider/0001733077","role":"Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16713.0,"shares_display":"16,713","price_per_share":0.94,"price_display":"0.94","price_state":"stated","total_value":15710.22,"total_display":"15,710.22","shares_owned_after":83193.0,"shares_owned_after_display":"83,193","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-01","filed_date":"2023-08-11","scope":"insider"},{"id":6305331,"accession":"0001209191-22-044673","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-044673","line_url":"/filing/0001209191-22-044673#line-1","is_derivative":false,"issuer_cik":"0001718108","issuer_name":"Surface Oncology, Inc.","issuer_ticker":"SURF","issuer_name_source":null,"issuer_url":"/issuer/0001718108","owner_cik":"0001733077","owner_name":"ROSS ROBERT W.","owner_url":"/insider/0001733077","role":"Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10594.0,"shares_display":"10,594","price_per_share":1.72,"price_display":"1.72","price_state":"stated","total_value":18221.68,"total_display":"18,221.68","shares_owned_after":99906.0,"shares_owned_after_display":"99,906","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-03","filed_date":"2022-08-05","scope":"insider"},{"id":6387814,"accession":"0001209191-22-003397","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-003397","line_url":"/filing/0001209191-22-003397#line-1","is_derivative":false,"issuer_cik":"0001718108","issuer_name":"Surface Oncology, Inc.","issuer_ticker":"SURF","issuer_name_source":null,"issuer_url":"/issuer/0001718108","owner_cik":"0001733077","owner_name":"ROSS ROBERT W.","owner_url":"/insider/0001733077","role":"Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33500.0,"shares_display":"33,500","price_per_share":6.1,"price_display":"6.10","price_state":"stated","total_value":204350.0,"total_display":"204,350.00","shares_owned_after":54500.0,"shares_owned_after_display":"54,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-21","filed_date":"2022-01-14","scope":"insider"},{"id":4716834,"accession":"0001209191-21-012182","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-012182","line_url":"/filing/0001209191-21-012182#line-1","is_derivative":false,"issuer_cik":"0001718108","issuer_name":"Surface Oncology, Inc.","issuer_ticker":"SURF","issuer_name_source":null,"issuer_url":"/issuer/0001718108","owner_cik":"0001733077","owner_name":"ROSS ROBERT W.","owner_url":"/insider/0001733077","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":11.35,"price_display":"11.35","price_state":"stated","total_value":11350.0,"total_display":"11,350.00","shares_owned_after":88000.0,"shares_owned_after_display":"88,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-16","filed_date":"2021-02-18","scope":"insider"},{"id":5422151,"accession":"0001209191-21-003916","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-003916","line_url":"/filing/0001209191-21-003916#line-2","is_derivative":false,"issuer_cik":"0001718108","issuer_name":"Surface Oncology, Inc.","issuer_ticker":"SURF","issuer_name_source":null,"issuer_url":"/issuer/0001718108","owner_cik":"0001733077","owner_name":"ROSS ROBERT W.","owner_url":"/insider/0001733077","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":12.25,"price_display":"12.25","price_state":"stated","total_value":24500.0,"total_display":"24,500.00","shares_owned_after":89000.0,"shares_owned_after_display":"89,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-15","filed_date":"2021-01-15","scope":"insider"},{"id":5422148,"accession":"0001209191-21-003916","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-003916","line_url":"/filing/0001209191-21-003916#line-1","is_derivative":false,"issuer_cik":"0001718108","issuer_name":"Surface Oncology, Inc.","issuer_ticker":"SURF","issuer_name_source":null,"issuer_url":"/issuer/0001718108","owner_cik":"0001733077","owner_name":"ROSS ROBERT W.","owner_url":"/insider/0001733077","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":11.95,"price_display":"11.95","price_state":"stated","total_value":83650.0,"total_display":"83,650.00","shares_owned_after":91000.0,"shares_owned_after_display":"91,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-14","filed_date":"2021-01-15","scope":"insider"},{"id":2914041,"accession":"0001209191-20-064253","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-064253","line_url":"/filing/0001209191-20-064253#line-1","is_derivative":false,"issuer_cik":"0001718108","issuer_name":"Surface Oncology, Inc.","issuer_ticker":"SURF","issuer_name_source":null,"issuer_url":"/issuer/0001718108","owner_cik":"0001733077","owner_name":"ROSS ROBERT W.","owner_url":"/insider/0001733077","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":10.48,"price_display":"10.48","price_state":"stated","total_value":10480.0,"total_display":"10,480.00","shares_owned_after":98000.0,"shares_owned_after_display":"98,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-15","filed_date":"2020-12-17","scope":"insider"},{"id":3174356,"accession":"0001209191-20-063630","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-063630","line_url":"/filing/0001209191-20-063630#line-1","is_derivative":false,"issuer_cik":"0001718108","issuer_name":"Surface Oncology, Inc.","issuer_ticker":"SURF","issuer_name_source":null,"issuer_url":"/issuer/0001718108","owner_cik":"0001733077","owner_name":"ROSS ROBERT W.","owner_url":"/insider/0001733077","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1405.0,"shares_display":"1,405","price_per_share":10.05,"price_display":"10.05","price_state":"stated","total_value":14120.25,"total_display":"14,120.25","shares_owned_after":99000.0,"shares_owned_after_display":"99,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-11","filed_date":"2020-12-15","scope":"insider"},{"id":3324887,"accession":"0001209191-20-058406","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-058406","line_url":"/filing/0001209191-20-058406#line-1","is_derivative":false,"issuer_cik":"0001718108","issuer_name":"Surface Oncology, Inc.","issuer_ticker":"SURF","issuer_name_source":null,"issuer_url":"/issuer/0001718108","owner_cik":"0001733077","owner_name":"ROSS ROBERT W.","owner_url":"/insider/0001733077","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":595.0,"shares_display":"595","price_per_share":10.05,"price_display":"10.05","price_state":"stated","total_value":5979.75,"total_display":"5,979.75","shares_owned_after":100405.0,"shares_owned_after_display":"100,405","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-11","filed_date":"2020-11-13","scope":"insider"},{"id":2048995,"accession":"0001209191-20-055191","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-055191","line_url":"/filing/0001209191-20-055191#line-1","is_derivative":false,"issuer_cik":"0001718108","issuer_name":"Surface Oncology, Inc.","issuer_ticker":"SURF","issuer_name_source":null,"issuer_url":"/issuer/0001718108","owner_cik":"0001733077","owner_name":"ROSS ROBERT W.","owner_url":"/insider/0001733077","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":10.05,"price_display":"10.05","price_state":"stated","total_value":40200.0,"total_display":"40,200.00","shares_owned_after":101000.0,"shares_owned_after_display":"101,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-14","filed_date":"2020-10-16","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":10,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":10,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":10},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001718108","name":"Surface Oncology, Inc.","url":"/issuer/0001718108","role":"Officer (Chief Executive Officer)","n_filings":9,"first_seen":"2020-10-16","last_seen":"2023-08-11"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001733077","retrieved_at":"2026-08-21T22:44:32+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}